Epithelial and connective tissue cell CTGF/CCN2 expression in gingival fibrosis

Kantarci A., Black S. A. , Xydas C. E. , Murawel P., Uchida Y., Yucekal-Tuncer B., ...More

JOURNAL OF PATHOLOGY, vol.210, no.1, pp.59-66, 2006 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 210 Issue: 1
  • Publication Date: 2006
  • Doi Number: 10.1002/path.2000
  • Title of Journal : JOURNAL OF PATHOLOGY
  • Page Numbers: pp.59-66
  • Keywords: gingival overgrowth, fibrosis, connective tissue growth factor, epithelium, fibroblast, epithelial-mesenchymal transition, CHONDROCYTE-SPECIFIC GENE, HEPATOCYTE GROWTH-FACTOR, MESENCHYMAL TRANSITION, FACTOR-BETA, FIBROMATOSIS, OVERGROWTH, TGF-BETA-1, COLLAGEN, DIFFERENTIATION, PROLIFERATION


Gingival overgrowth is a side effect of certain medications and occurs in non-drug-induced School of Dental Medicine, 700 Albany Street induced forms either as inherited (human gingival fibromatosis) or idiopathic gingival overgrowth. The most fibrotic drug-induced lesions develop in response to therapy with phenytoin; the least fibrotic lesions are caused by cyclosporin A; and intermediate fibrosis occurs in nifedipine-induced gingival overgrowth. Connective tissue growth factor (CTGF/CCN2) expression is positively related to the degree of fibrosis in these tissues. The present study has investigated the hypothesis that CTGF/CCN2 is expressed in human gingival fibromatosis tissues and contributes to this form of non-drug-induced gingival overgrowth. Histopathology/immunohistochemistry studies showed that human gingival fibromatosis lesions are highly fibrotic, similar to phenytoin-induced lesions. Connective tissue CTGF/CCN2 levels were equivalent to the expression in phenytoin-induced gingival overgrowth. The additional novel observation was made that CTGF/CCN2 is highly expressed in the epithelium of fibrotic gingival tissues. This finding was confirmed by in situ hybridization. Real-time polymerase chain reaction (PCR) analyses of RNA extracted from drug-induced gingival overgrowth tissues for CTGF/CCN2 were fully consistent with these findings. Finally, normal primary gingival epithelial cell cultures were analysed for basal and ktransforming growth factor beta 1 (TGF-beta 1) or lysophosphatidic acid-stimulated CTGF/CCN2 expression at protein and RNA levels. These data indicate that fibrotic human gingival tissues express CTGF/CCN2 in both the epithelium and connective tissues; that cultured gingival epithelial cells express CTGF/CCN2; and that lysophosphatidic acid further stimulates CTGF/CCN2 expression. These findings suggest that interactions between epithelial and connective tissues could contribute to gingival fibrosis. Copyright (c) 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.